Cargando…

Potent USP10/13 antagonist spautin‐1 suppresses melanoma growth via ROS‐mediated DNA damage and exhibits synergy with cisplatin

Malignant melanoma is one of the most invasive tumours. However, effective therapeutic strategies are limited, and overall survival rates remain low. By utilizing transcriptomic profiling, tissue array and molecular biology, we revealed that two key ubiquitin‐specific proteases (USPs), ubiquitin‐spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jia, Zhang, JiangLing, Liang, Long, Liu, Nian, Qi, Min, Zhao, Shuang, Su, Juan, Liu, Jing, Peng, Cong, Chen, Xiang, Liu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171391/ https://www.ncbi.nlm.nih.gov/pubmed/32129945 http://dx.doi.org/10.1111/jcmm.15093

Ejemplares similares

The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism
por: Pesce, Emanuela, et al.
Publicado: (2018)

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
por: Liao, Yuning, et al.
Publicado: (2019)

Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia
por: Shao, Shan, et al.
Publicado: (2014)

Structure–Activity Relationship (SAR) Study of Spautin-1 to Entail the Discovery of Novel NEK4 Inhibitors
por: Elsocht, Mathias, et al.
Publicado: (2021)

Tirapazamine-cisplatin: the synergy.
por: Gatzemeier, U., et al.
Publicado: (1998)

Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2021)

Inhibition of ubiquitin-specific protease 13-mediated degradation of Raf1 kinase by Spautin-1 has opposing effects in naïve and primed pluripotent stem cells
por: Wang, Xin, et al.
Publicado: (2021)

Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation
por: Kunimasa, Kazuhiro, et al.
Publicado: (2022)

USP48/USP31 Is a Nuclear Deubiquitinase that Potently Regulates Synapse Remodeling
por: Ma, Qi, et al.
Publicado: (2023)

Pharmacological inhibition of USP7 suppresses growth and metastasis of melanoma cells in vitro and in vivo
por: Xiang, Minmin, et al.
Publicado: (2021)

The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells
por: Schott, Courtney R., et al.
Publicado: (2018)

Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels
por: Li, Jiaoduan, et al.
Publicado: (2022)

Deubiquitination and stabilization of PTEN by USP13
por: Zhang, Jinsong, et al.
Publicado: (2013)

Role of USP13 in physiology and diseases
por: Wang, Qian, et al.
Publicado: (2022)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
por: Zhang, Qian, et al.
Publicado: (2022)

Amplification of USP13 drives ovarian cancer metabolism
por: Han, Cecil, et al.
Publicado: (2016)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

Role of ROS-mediated autophagy in melanoma
por: Zhang, Xuebing, et al.
Publicado: (2022)

Antagonistic Interactions in Mitochondria ROS Signaling Responses to Manganese
por: Fernandes, Jolyn, et al.
Publicado: (2023)

Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
por: Marzęda, Paweł, et al.
Publicado: (2022)

USP13: Multiple Functions and Target Inhibition
por: Li, Xiaolong, et al.
Publicado: (2022)

Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
por: Sagar, Jayesh, et al.
Publicado: (2009)

Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma
por: Guo, Weinan, et al.
Publicado: (2018)

A Potent Antagonist of Smoothened in Hedgehog Signaling for Epilepsy
por: Fan, Junwan, et al.
Publicado: (2022)

Identification of a potent antagonist of smoothened in hedgehog signaling
por: Fan, Junwan, et al.
Publicado: (2021)

Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma
por: Cui, Jinfang, et al.
Publicado: (2023)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
por: Jalili, Ahmad, et al.
Publicado: (2013)

Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma
por: Liu, Yufeng, et al.
Publicado: (2020)

CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer
por: Chen, Jingxuan, et al.
Publicado: (2022)

USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication
por: Pan, Ting, et al.
Publicado: (2019)

The regulation of NONO by USP11 via deubiquitination is linked to the proliferation of melanoma cells
por: Feng, Peifu, et al.
Publicado: (2020)

Functional synergy between the Munc13 C-terminal C(1) and C(2) domains
por: Liu, Xiaoxia, et al.
Publicado: (2016)

Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines—An Isobolographic Analysis
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2022)

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer
por: Xin, Qian, et al.
Publicado: (2022)

Correction: NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
por: Jalili, Ahmad, et al.
Publicado: (2013)

USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer
por: Fu, Ying, et al.
Publicado: (2018)

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
por: Corno, Cristina, et al.
Publicado: (2022)

USP13 antagonizes gp78 to maintain functionality of a chaperone in ER-associated degradation
por: Liu, Yanfen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0fhsv8q7u43hhm7ftkpnljl3cn